Five-Year Safety and Efficacy of Belatacept in Renal Transplantation

Belatacept is a first-in-class co-stimulation blocker in development for primary maintenance immunosuppression. A Phase II study comparing belatacept with cyclosporine (CsA) for prevention of acute rejection and protection of renal function in kidney transplant recipients demonstrated similar effica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vincenti, Flavio, Blancho, Gilles, Durrbach, Antoine, Friend, Peter, Grinyo, Josep, Halloran, Philip F., Klempnauer, Jurgen, Lang, Philippe, Larsen, Christian P., Mühlbacher, Ferdinand, Nashan, Björn, Soulillou, Jean-Paul, Vanrenterghem, Yves, Wekerle, Thomas, Agarwal, Mamta, Gujrathi, Sheila, Shen, Jinshan, Shi, Rebecca, Townsend, Robert, Charpentier, Bernard
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2010
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3013525/
https://ncbi.nlm.nih.gov/pubmed/20634298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009111109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados